← Back to Search

Dietary Supplement

Acacia Gum for Heart Failure (FEAST-HF Trial)

N/A
Waitlist Available
Led By Justin Ezekowitz, MBBCh
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 6, week 12
Awards & highlights

Summary

This trial will study whether a dietary supplement of acacia gum can reduce markers of heart failure, and how the gut microbiome responds to this supplement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 6, week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 6, week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
NT-proBNP
Secondary study objectives
6-Minute Walk Test
Composite Clinical Outcomes
Fecal Microbiome Characterization
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Acacia Gum 5 grams/dayExperimental Treatment1 Intervention
fermentable dietary fiber
Group II: Acacia Gum 10 grams/dayExperimental Treatment1 Intervention
fermentable dietary fiber
Group III: Microcrystalline Cellulose (MCC) 10 grams/dayActive Control1 Intervention
non-fermentable active control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acacia Gum
2018
N/A
~60

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
913 Previous Clinical Trials
390,382 Total Patients Enrolled
26 Trials studying Heart Failure
5,894 Patients Enrolled for Heart Failure
Justin Ezekowitz, MBBChPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
806 Total Patients Enrolled
1 Trials studying Heart Failure
806 Patients Enrolled for Heart Failure
~7 spots leftby Sep 2025